Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics Corp (UTHR) · filed Dec 16, 2025

Accession no.
0001673232-25-000016
Filed
Dec 16, 2025
Trade date
Dec 15, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 22 non-derivative transactions and 2 derivative transactions. Open-market sales total $11.2M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 15, 2025Common StockMOption exerciseAcquired+14,625$117.76+$1,722,24014,625Indirect
Dec 15, 2025Common StockSSaleDisposed−260$491.18−$127,706.814,365Indirect
Dec 15, 2025Common StockSSaleDisposed−1,466$492.31−$721,726.4612,899Indirect
Dec 15, 2025Common StockSSaleDisposed−2,596$493.25−$1,280,47710,303Indirect
Dec 15, 2025Common StockSSaleDisposed−1,446$494.13−$714,511.988,857Indirect
Dec 15, 2025Common StockSSaleDisposed−1,442$495.29−$714,208.186,076Indirect
Dec 15, 2025Common StockSSaleDisposed−1,339$496.16−$664,358.247,518Indirect
Dec 15, 2025Common StockSSaleDisposed−520$497.42−$258,658.45,556Indirect
Dec 15, 2025Common StockSSaleDisposed−1,222$498.22−$608,824.844,334Indirect
Dec 15, 2025Common StockSSaleDisposed−598$499.57−$298,742.863,736Indirect
Dec 15, 2025Common StockSSaleDisposed−3,736$500.31−$1,869,158.160Indirect
Dec 15, 2025Common StockMOption exerciseAcquired+7,875$478.58+$3,768,817.57,875Indirect
Dec 15, 2025Common StockSSaleDisposed−140$491.18−$68,765.27,735Indirect
Dec 15, 2025Common StockSSaleDisposed−789$492.31−$388,432.596,946Indirect
Dec 15, 2025Common StockSSaleDisposed−1,398$493.25−$689,563.55,548Indirect
Dec 15, 2025Common StockSSaleDisposed−779$494.13−$384,927.274,769Indirect
Dec 15, 2025Common StockSSaleDisposed−777$495.29−$384,840.333,992Indirect
Dec 15, 2025Common StockSSaleDisposed−720$496.16−$357,235.23,272Indirect
Dec 15, 2025Common StockSSaleDisposed−280$497.42−$139,277.62,992Indirect
Dec 15, 2025Common StockSSaleDisposed−658$498.22−$327,828.762,334Indirect
Dec 15, 2025Common StockSSaleDisposed−322$499.57−$160,861.542,012Indirect
Dec 15, 2025Common StockSSaleDisposed−2,012$500.31−$1,006,623.720Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 15, 2025Common StockMOption exerciseDisposed−14,625$0.00$0141,000Indirect
Dec 15, 2025Common StockMOption exerciseDisposed−7,875$0.00$06,190Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)